LAMEA Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025

The Latin America, Middle East and Africa Tumor Ablation Market would witness market growth of 13.2% CAGR during the forecast period (2019-2025). The ablation market for tumors in the Middle East & Africa is fueled by factors such as the growing aging population and the increased number of people suffering from cancer. An increase in the demand for minimally invasive cancer treatment procedures and high awareness of the benefits that ablation procedures offer over conventional surgical procedures are also among the key factors that add up to market growth.

Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by health care professionals of the microwave tumor ablation procedure to treat different cancers.

The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.

Based on Product Type, the market is segmented into Iodinated, Barium-based, Gadolinium-based and Microbubble. Based on Application, the market is segmented into Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications. Based on Modality, the market is segmented into X-ray/CT, MRI and Ultrasound. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: Tumor Ablation Market in LAMEA is expected to register a CAGR of 13.2% during the forecast period (2019-2025)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.

Scope of the Tumor Ablation Market Analysis

Market Segmentation:

By Treatment

• Surgical Ablation
• Laparoscopic Ablation and
• Percutaneous Ablation

By Technology

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation and
• Other Technology

By Application

• Liver Cancer
• Breast Cancer
• Lung Cancer
• Kidney Cancer
• Prostate Cancer and
• Other Cancer

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• Medtronic PLC
• Johnson and Johnson (Ethicon, Inc.)
• Boston Scientific Corporation
• Misonix, Inc.
• EDAP TMS S.A.
• Theraclion SA
• AngioDynamics, Inc.
• Mermaid Medical A/S
• HealthTronics, Inc. (Altaris Capital Partners, LLC)
• SonaCare Medical, LLC

Unique Offerings from KBV Research

• Exhaustive coverage
• The Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Tumor Ablation Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market